Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 4/20 | 0.64 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | CTSB | P07858 | 3/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 6/20 | 0.44 |
| ▸ | CASP6 | P55212 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | APEX1 | P27695 | 1/20 | 0.44 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.44 |
| ▸ | ABAT | P80404 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL145978 | 0.98 | GPR35 (0.67) | GPR35TSHRSMN1; SMN2CTSBTP53 | |
| SCHEMBL17512851 | 0.96 | GPR35 (0.64) | GPR35TSHRSMN1; SMN2CTSBTP53 | |
| Water SCHEMBL28180163 | 0.96 | GPR35 (0.64) | GPR35TSHRSMN1; SMN2CTSBTP53 | |
| Hydrochloric Acid SCHEMBL6372499 | 0.96 | GPR35 (0.64) | GPR35TSHRSMN1; SMN2CTSBTP53 | |
| SCHEMBL28638066 | 0.96 | GPR35 (0.64) | GPR35TSHRSMN1; SMN2CTSBTP53 | |
| SCHEMBL27270155 | 0.96 | GPR35 (0.64) | GPR35TSHRSMN1; SMN2CTSBTP53 | |
| Chloroform SCHEMBL28591707 | 0.90 | GPR35 (0.58) | GPR35TSHRSMN1; SMN2CTSBTP53 | |
| SCHEMBL10727444 | 0.88 | GPR35 (0.85) | GPR35TSHRSMN1; SMN2CTSBTP53 | |
| Naphthalene SCHEMBL28853785 | 0.88 | GPR35 (0.61) | GPR35TSHRSMN1; SMN2CTSBTP53 | |
| Phenol SCHEMBL28144767 | 0.87 | GPR35 (0.59) | GPR35TSHRSMN1; SMN2CTSBTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1745156-A2 | METHODS FOR DETECTING CHROMOSOME ABERRATIONS | Dako Denmark A/S (DK) | 2007-01-24 | — | — | EP | claimed |
| US-20060078904-A1 | Methods for detecting chromosome aberrations | DAKO DENMARK APS (DK) | 2006-04-13 | — | — | US | claimed |
| WO-2005111235-A2 | METHODS FOR DETECTING CHROMOSOME ABERRATIONS | DAK DENMARK A/S (US) | 2005-11-24 | — | — | WO | claimed |
| US-12291738-B2 | Methods and/or use of oligonucleotide conjugates for assays and flow cytometry detections | THE UNIVERSITY OF CHICAGO (US) | 2025-05-06 | — | — | US | disclosed |
| CN-118159563-A | Methods for enhanced BCMA immunohistochemical detection in human and monkey tissues | 詹森生物科技公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-115776987-A | Barcoded exchangeable peptide-MHC multimer libraries | 瑞佩尔托利免疫医药股份有限公司 | 2023-03-10 | — | — | CN | disclosed |
| US-20220170073-A1 | METHODS AND/OR USE OF OLIGONUCLEOTIDE CONJUGATES FOR ASSAYS AND FLOW CYTOMETRY DETECTIONS | THE UNIVERSITY OF CHICAGO (US) | 2022-06-02 | — | — | US | disclosed |
| US-11029303-B2 | PAH antibodies and uses thereof | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2021-06-08 | — | — | US | disclosed |
| EP-3733871-A1 | COMPOSITIONS AND METHODS FOR DETECTION OF CHROMOSOMAL ABERRATIONS WITH NOVEL HYBRIDIZATION BUFFERS | Dako Denmark A/S (DK) | 2020-11-04 | — | — | EP | disclosed |
| EP-2636756-B2 | COMPOSITIONS AND METHODS FOR DETECTION OF CHROMOSOMAL ABERRATIONS WITH NOVEL HYBRIDIZATION BUFFERS | DAKO DENMARK AS (DK) | 2019-11-20 | — | — | EP | disclosed |
| EP-2285982-B1 | COMPOSITIONS AND METHODS FOR DETECTION OF CHROMOSOMAL ABERRATIONS WITH NOVEL HYBRIDIZATION BUFFERS | DAKO DENMARK AS (DK) | 2018-04-11 | — | — | EP | disclosed |
| WO-2008045819-A2 | DETECTION AND IDENTIFICATION OF ORGANISMS VIA ANALYSIS OF NUCLEIC ACID SEQUENCES | BIOVERIS CORPORATION (US) | 2008-04-17 | — | — | WO | disclosed |
| US-7306916-B2 | Methods for detecting chromosome aberrations | DAKO DENMARK A/S (DK) | 2007-12-11 | — | — | US | disclosed |
| EP-1751316-A2 | NUCLEIC ACID PROBES AND NUCLEIC ACID ANALOG PROBES | Dako Denmark A/S (DK) | 2007-02-14 | — | — | EP | disclosed |
| EP-1745156-A2 | METHODS FOR DETECTING CHROMOSOME ABERRATIONS | Dako Denmark A/S (DK) | 2007-01-24 | — | — | EP | disclosed |
| WO-2007005626-A1 | COMPOSITIONS AND METHODS FOR DETECTING, AMPLIFYING, AND/OR ISOLATING NUCLEIC ACIDS | BIOVERIS CORPORATION (US) | 2007-01-11 | — | — | WO | disclosed |
| WO-2006117596-A2 | NUCLEIC ACID PROBES AND NUCLEIC ACID ANALOG PROBES | DAKO DENMARK A/S (US) | 2006-11-09 | — | — | WO | disclosed |
| US-20060078904-A1 | Methods for detecting chromosome aberrations | DAKO DENMARK APS (DK) | 2006-04-13 | — | — | US | disclosed |
| US-20050266459-A1 | Nucleic acid probes and nucleic acid analog probes | DAKOCYTOMATION DENMARK A/S (DK) | 2005-12-01 | — | — | US | disclosed |
| WO-2005111235-A2 | METHODS FOR DETECTING CHROMOSOME ABERRATIONS | DAK DENMARK A/S (US) | 2005-11-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11029303-B2 | PAH antibodies and uses thereof | PAH, AHR, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | GPR35 751/4885TSHR 3293/4885SMN1; SMN2 4884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.